Anxiety disorders are the most common childhood-onset psychiatric disorders, affecting approximately one in eight children. Childhood anxiety disorders typically follow a progressive course, leading to additional psychopathology. In addition, childhood anxiety disorders often impede social, emotional, and academic development. Early intervention can modify the trajectory of the disorder and prevent significant impairment. When childhood anxiety disorders are not sufficiently treated, they often persist into adulthood and are associated with depression, substance abuse, functional and occupational impairments, and suicidal behavior.
A range of treatments for anxiety disorders in children and adolescents—including psychological, pharmacologic, and combined treatment approaches—are currently available. Despite the range of available treatments, uncertainty remains regarding the most effective interventions and sequences of care.
As part of PCORI’s efforts to fund high-impact and useful research on critical patient-centered health and healthcare issues, PCORI convened a multi-stakeholder workshop to discuss the state of evidence and the most pressing research needs for treatment of anxiety in children, adolescents, and young adults. PCORI will use feedback from this workshop to better understand these research needs, and how comparative effectiveness research could address these needs, as we explore a possible funding announcement in this area.
Participation in this workshop was by invitation only, but the public was welcome to listen in via teleconference/webinar.